![logo](/logos/000627.SZ.webp)
Hubei Biocause Pharmaceutical Co., Ltd.
SZSE:000627.SZ
3.07 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Hubei Biocause Pharmaceutical Co., Ltd. |
Symbool | 000627.SZ |
Munteenheid | CNY |
Prijs | 3.1 |
Beurswaarde | 15,315,953,050 |
Dividendpercentage | 4.74% |
52-weken bereik | 2.79 - 3.91 |
Industrie | Insurance—Life |
Sector | Financial Services |
CEO | Ms. Wenxia Zhou |
Website | https://www.biocause.com |
An error occurred while fetching data.
Over Hubei Biocause Pharmaceutical Co., Ltd.
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)